Beacon Therapeutics reveals promising interim results for laru-zova, a gene therapy showing potential to improve vision in ...

With Episodes wrapped up, Destiny 2’s content model is being totally overhauled, and players may want to know what new ...

The FDA extended aficamten's review by three months for REMS safety program finalization, causing Cytokinetics' stock to drop ...